Pieris Pharmaceuticals Long-Term Investments 1970-1969 | PVLA
Pieris Pharmaceuticals long-term investments from 1970 to 1969. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Pieris Pharmaceuticals Annual Long-Term Investments
(Millions of US $) |
Pieris Pharmaceuticals Quarterly Long-Term Investments
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
|
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|
